Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse

Trial Profile

Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Doxazosin (Primary)
  • Indications Cocaine abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 28 Mar 2014 Planned initiation date changed from 1 Oct 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
    • 08 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top